CVRx CVRX
NASDAQ CVRX
$2.84 +0.02 (+0.71%)
At close: Aug 20, 2026 · 4:00 PM EDT

CVRx (CVRX) Operating Leases (2021 - 2026)

CVRx (CVRX) posted quarterly Operating Leases of $544000.0 for Q1 2026, down 32.17% year-over-year from $802000.0 in Q1 2025, and down 14.73% quarter-over-quarter from $638000.0 in Q4 2025.

CVRx (CVRX) Operating Leases (2021 - 2026) Analysis & Trends

CVRx's Operating Leases history runs 6 years deep, the most recent figure standing at $544000.0 for Q1 2026.

  • In Q1 2026, Operating Leases fell 32.17% year-over-year to $544000.0; the TTM figure through Mar 2026 stood at $544000.0 (down 32.17% YoY), while the FY2025 annual figure was $638000.0, down 27.25% from the prior year.
  • Operating Leases for Q1 2026 stood at $544000.0, down from $638000.0 in the prior quarter.
  • The five-year high for Operating Leases was $1.2 million in Q4 2023, with the low at $59000.0 in Q1 2023.
  • The 5-year median for Operating Leases is $802000.0 (2025), against an average of $670764.7.
  • The sharpest annual moves came in 2023 and 2024: Operating Leases slumped 80.59% in 2023, then soared 1750.85% in 2024.
  • CVRx's Operating Leases stood at $117000.0 in 2022, then surged by 891.45% to $1.2 million in 2023, then dropped by 24.4% to $877000.0 in 2024, then dropped by 27.25% to $638000.0 in 2025, then slipped by 14.73% to $544000.0 in 2026.
  • Business Quant data shows CVRX's Operating Leases at $544000.0 in Q1 2026, $638000.0 in Q4 2025, and $730000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn
10 CVRx 74.38 Mn 9.79 Mn 13.72 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 819,000.00
Mar 31, 2026 544,000.00
Dec 31, 2025 638,000.00
Sep 30, 2025 730,000.00
Jun 30, 2025 819,000.00
Mar 31, 2025 802,000.00
Dec 31, 2024 877,000.00
Sep 30, 2024 951,000.00
Jun 30, 2024 1.02 Mn
Mar 31, 2024 1.09 Mn
Dec 31, 2023 1.16 Mn
Sep 30, 2023 916,000.00
Jun 30, 2023 946,000.00
Mar 31, 2023 59,000.00
Dec 31, 2022 117,000.00
Sep 30, 2022 175,000.00
Jun 30, 2022 250,000.00
Mar 31, 2022 304,000.00
Mar 31, 2021 512,000.00